StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Zivo Bioscience's profit margin for the twelve months ending Sep 30, 2025 was -4059.7%. For fiscal 2024 it was -8513.4%, against -28127.2% the year before. The highest annual figure on record is -2629.3% in fiscal 2011.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-8513.4%+19613.8
FY2023Dec 31, 2023-28127.2%+17401.4
FY2020Dec 31, 2020-45528.6%−42899.3
FY2011Dec 31, 2011-2629.3%+5980.5
FY2010Dec 31, 2010-8609.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 2025-1574.2%+2005.0
Q2 FY2025Jun 30, 2025-3071.6%+13102.5
Q4 FY2024Dec 31, 2024-1779.3%+13686.1
Q3 FY2024Sep 30, 2024-7201.9%+43923.3
Q1 FY2024Mar 31, 2024-3579.2%+9135.7
Q4 FY2023Dec 31, 2023-16174.1%–
Q3 FY2023Sep 30, 2023-15465.4%–
Q2 FY2023Jun 30, 2023-51125.2%–
Q1 FY2020Mar 31, 2020-12714.9%–

More Zivo Bioscience figures

See a number that looks wrong?